In Novo Nordisk A/S’s home country of Denmark, the popularity of weight-loss drugs is fueling economic growth, but local ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Health plan trustees at a Minneapolis-based construction workers union are suing a subsidiary of UnitedHealth Group for ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

From legal pitfalls to temperature-sensitive drugs, here’s how to travel safely and legally with your medication ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...

The Financial Supervisory Service issued its latest consumer advisory pertaining to insurance claims for various forms of ...

US hospitals recommend the MEAL plan for patients taking weight loss medications such as Wegovy and Ozempic Learn how this ...